Biotech Innovations: From AI to Bio-Agriculture ⸺ Hong Kong's Path Towards a Biotech Hub (Session 1&2)
Biotech Innovations: From AI to Bio-Agriculture ⸺ Hong Kong's Path Towards a Biotech Hub (Session 1&2)
团结香港基金（基金会）日前举办了“团结卓尔论坛”新经济系列，以“Biotech Innovations: From AI to Bio-Agriculture — Hong Kong’s Path Towards a Biotech Hub”为题，深入探讨如何运用人工智能推动药物研发。
论坛邀得新元资本创始人及高级合夥人宋红方女士为主讲嘉宾，演讲分为两节，内容包括人工智能助力微创医疗，及革新兼具快捷与智能化的救生诊断技术。宋红方女士表示：“传统药物开发失败率高达95%及造成每年600亿美元浪费，透过新元资本专属AI平台‘ORIzon’，从患者需求出发，优化靶点识别、分子构建及临床试验，缩短开发时程40至60%、降低540亿美元研发成本，并增加16.7%成功率。”
是次分享会座无虚席，获各行各业的企业高管、行业翘楚参与以及各界大力支持；同系列主题的第二场论坛将于11月14日举行。
Join us for a thought-provoking two-day Insight Forum, partnering with ORI Capital and featuring renowned biotech leader, Simone Song, Founder and Senior Partner of ORI Capital. The forum will explore how AI can be harnessed to advance innovation in drug development, diagnostics, MedTech, bio-agriculture and beyond.
Don’t miss this unique opportunity to engage with industry experts and discover actionable strategies that will shape the future of biotech in Hong Kong and beyond. Whether you are a biotech strategist, healthcare practitioner, policymaker, or innovation enthusiast, this series will equip you with the knowledge and networks needed to accelerate progress in Hong Kong’s vibrant biotech ecosystem.
Join all sessions to receive a Certificate of Attendance, acknowledging your full commitment and active participation.
团结香港基金（基金会）日前举办了“团结卓尔论坛”新经济系列，以“Biotech Innovations: From AI to Bio-Agriculture — Hong Kong’s Path Towards a Biotech Hub”为题，深入探讨如何运用人工智能推动药物研发。
论坛邀得新元资本创始人及高级合夥人宋红方女士为主讲嘉宾，演讲分为两节，内容包括人工智能助力微创医疗，及革新兼具快捷与智能化的救生诊断技术。宋红方女士表示：“传统药物开发失败率高达95%及造成每年600亿美元浪费，透过新元资本专属AI平台‘ORIzon’，从患者需求出发，优化靶点识别、分子构建及临床试验，缩短开发时程40至60%、降低540亿美元研发成本，并增加16.7%成功率。”
是次分享会座无虚席，获各行各业的企业高管、行业翘楚参与以及各界大力支持；同系列主题的第二场论坛将于11月14日举行。
Join us for a thought-provoking two-day Insight Forum, partnering with ORI Capital and featuring renowned biotech leader, Simone Song, Founder and Senior Partner of ORI Capital. The forum will explore how AI can be harnessed to advance innovation in drug development, diagnostics, MedTech, bio-agriculture and beyond.
Don’t miss this unique opportunity to engage with industry experts and discover actionable strategies that will shape the future of biotech in Hong Kong and beyond. Whether you are a biotech strategist, healthcare practitioner, policymaker, or innovation enthusiast, this series will equip you with the knowledge and networks needed to accelerate progress in Hong Kong’s vibrant biotech ecosystem.
Join all sessions to receive a Certificate of Attendance, acknowledging your full commitment and active participation.
